Samsung Electronics (SMSN.UK) rose more than 4%, marking its highest point since January 2021. Also other Korean giant SK Hynix surged today on OpenAI deal news.
-
The rally followed news that both companies partnered with OpenAI as part of its Stargate initiative. SK Hynix is already a key supplier to Nvidia, while Samsung is pushing to get its own HBM4 chips certified by Nvidia.
-
The partnership aims to boost the supply of advanced memory chips and expand AI-focused data center capacity in South Korea. Despite Samsung’s chip business profits falling 94% year-on-year in Q2, its CFO expressed optimism for a rebound in the second half of 2025.
-
OpenAI CEO Sam Altman met with South Korean President Lee Jae Myung and top executives from Samsung and SK Hynix to seal the collaboration.
-
OpenAI also signed agreements with the Korean Ministry of Science and ICT, SK Telecom, and Samsung subsidiaries to explore building next-gen AI data centers in Korea.
-
SK Hynix recently announced mass production readiness for its high-bandwidth memory (HBM) chips, which are vital for powering AI applications, including Nvidia’s GPUs.
-
The upcoming HBM4 chips are expected to be crucial for Nvidia’s next-generation Rubin AI architecture.
-
Once the dominant memory leader, Samsung now faces stronger competition from SK Hynix, which has caught up in memory revenues according to Counterpoint Research.
Source: xStation5
US OPEN: Market extends decline at the end of the week
Constellation Energy: Mixed Results for Q3 2025
More Expensive Chips, More Expensive Devices – TSMC is Changing the Rules!
Hensoldt Rises Thanks to Record Backlog and Growth Plans!
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
